Romlus 0.03% Ointment 10g - Effective Relief for Skin Conditions
Romlus 0.03% Ointment 10g contains Tacrolimus 0.03% w/w, a topical calcineurin inhibitor used as second-line therapy for moderate to severe atopic dermatitis (eczema) in children aged 2 years and older when conventional therapies are inadvisable or inadequate. It controls inflammation without the skin-thinning effects of corticosteroids.
Pay in 3 Installments of
Rs.
189
Romlus 0.03% Ointment 10g - Effective Relief for Skin Conditions
Description
Romlus Ointment: A Detailed Overview for Dermatological Treatment
Composition:
Romlus Ointment is
available in two variations, containing either 01% or 003% Tacrolimus per gram,
providing a potent solution for various dermatological conditions
Description:
Romlus, containing
Tacrolimus as its active ingredient, acts as a macrocyclic immunosuppressant
derived from Streptomyces tsukubaensis It demonstrates an inhibitory effect on
Tlymphocyte activation, effectively controlling the release of inflammatory
mediators from skin mast cells, eosinophils, and basophils
Indications:
Primarily indicated
for the treatment of severe atopic dermatitis (eczema) in adults, Romlus
Ointment offers short-term and intermittent long-term therapy for managing
moderate to severe dermatological conditions
Dosage & Administration:
For effective
results, Romlus Ointment should be applied twice daily, with a recommended
interval of 12 hours between applications It is crucial to continue the
treatment for at least one week after the resolution of atopic dermatitis
symptoms
Side Effects:
Mild to moderate side
effects, including a burning sensation, pruritus, and erythema, were commonly
reported during the use of Ointment Alcohol intolerance and increased
skin sensitivity were also observed as potential adverse reactions
In conclusion, Romlus Ointment, fortified with Tacrolimus,
serves as a promising dermatological solution for managing severe atopic
dermatitis and related conditions While certain side effects have been noted,
its clinical efficacy and targeted action make it a valuable therapeutic option
It is essential to adhere to the prescribed dosage and heed the necessary
precautions for safe and effective usage
Usage & Benefits
- Tacrolimus 0.03% topical calcineurin inhibitor for paediatric eczema
- Effective on face, eyelids, neck, and skin folds where steroids are risky
- Does not cause skin thinning, stretch marks, or telangiectasia
- Reduces flare frequency when used for maintenance twice weekly after control
- Steroid-sparing option for chronic atopic dermatitis
How To Use
- Apply a thin layer of Romlus 0.03% Ointment to affected skin twice daily.
- Continue until 1 week after lesions clear, then stop or move to maintenance.
- Maintenance: apply twice weekly to previously affected areas.
- Wash hands after application unless hands are being treated.
- Use sun protection (sunscreen, protective clothing) on treated areas.
- Do not use under occlusive dressings; avoid alcohol while treated areas are uncovered as flushing may occur.
FAQs
What is Romlus 0.03% Ointment used for?
For moderate to severe atopic dermatitis in children aged 2 and older when standard therapies are not suitable.
How is it different from a steroid?
Tacrolimus is a calcineurin inhibitor; it does not cause skin thinning, so it is preferred for face, eyelids, neck, and skin folds.
Are there any boxed warnings?
Yes. Topical calcineurin inhibitors carry an FDA boxed warning about a possible association with lymphoma and skin cancer; use the lowest effective amount for the shortest time.
What are common side effects?
Burning, itching, warmth, and flushing after alcohol intake.
Is a prescription required?
Yes, prescription required.
Dermatologist Recommended
Healer's Pharma Minoxidil 5% + Finasteride 0.25% Hair Regrowth Spray
0.25% Finasteride Topical Hair Loss Spray by Healer's Pharma
